Laval, QC – June 03, 2025 – Corealis Pharma, a premier Contract Development and Manufacturing Organization (CDMO) with two decades of proven expertise in oral solid dose (OSD) formulation development and clinical GMP manufacturing, is proud to announce its integration into the Prendio procurement platform. This strategic move enhances Corealis’ accessibility to biotech innovators through a secure, transparent, and rigorously vetted sourcing ecosystem.
Prendio’s selective partner vetting process ensures that only organizations with a proven track record of excellence and reliability are authorized to offer services through its platform. Corealis’ inclusion reflects its unwavering commitment to quality, scientific rigor, and client-focused solutions.
“Our presence on the Prendio platform further validates Corealis Pharma’s position as a trusted leader in the early-stage CDMO industry” said David Leroux-Petersen, CEO of Corealis Pharma. “We are excited to offer our proven capabilities through a platform that prioritizes credibility, compliance, and efficiency. This milestone strengthens our ability to support biotech and pharma companies as they seek early-stage CDMO partners that truly accelerate their path to clinical trials.”
The Prendio platform provides clients with a seamless and efficient portal to connect with Corealis Pharma to initiate proposals, align project needs, and manage communication within an intuitive, user-friendly digital environment. This integration enables streamlined access to complex services.
By leveraging our preferred vendor status, companies using Prendio-BioProcure gain Corealis Pharma’s comprehensive suite of specialized services, including:
- Preformulation and drug product assessment
- Formulation development
- Analytical method development and validation
- GMP manufacturing for clinical trials
This partnership underscores Corealis Pharma’s enduring reputation for delivering scientifically sound, regulatory-compliant, and scalable oral solid dose solutions, qualities that have consistently made it the top CDMO of choice for early-stage biotech innovators.
About Prendio
Prendio-BioProcure provides specialized procurement solutions tailored for the life sciences industry. Designed for biotechs, our software and services streamline purchasing, ensure compliance, and enable companies to stay focused on innovation. Learn more at prendio.com
About Corealis Pharma
Founded in 2005, Corealis Pharma is a leading early-stage CDMO with expertise in the formulation development and manufacturing of oral solid dosage (OSD) forms for the pharmaceutical and biotech industries. With a reputation for technical excellence, agility, and a client-centric approach, Corealis provides a comprehensive suite of services from early-stage formulation to GMP clinical trial material manufacture.
Renowned for its scientific excellence, operational agility, and commitment to client success, Corealis delivers customized solutions from early-stage development through to clinical trial material production.
For inquiries, please contact:
Patrick Frankham, VP, Business Development
Corealis Pharma Inc.
Email: patrick.frankham@corealispharma.com
Phone: +1 (450) 973-7505
Website: www.corealispharma.com
Contact Corealis
Corealis’ experts are ready to answer any queries about the company’s oral solid dose offering, including its development and manufacturing capabilities.
